Description
Cabozantinib is a targeted therapy medication used to treat certain types of cancer. It works by inhibiting multiple receptor tyrosine kinases, which are proteins involved in cancer growth and spread.
Cabozantinib is approved for the treatment of advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer) in patients who have previously received other treatments.
It may also be used to treat certain forms of thyroid cancer. Cabozantinib is typically taken orally in the form of a capsule once daily.
Common side effects may include fatigue, diarrhea, decreased appetite, high blood pressure, and hand-foot syndrome. It’s important for patients to discuss potential risks and benefits with their healthcare provider before starting cabozantinib therapy. Regular monitoring and follow-up appointments are usually recommended during treatment.
